181 related articles for article (PubMed ID: 20859258)
1. Gene therapy of canine leukocyte adhesion deficiency using lentiviral vectors with human CD11b and CD18 promoters driving canine CD18 expression.
Hunter MJ; Tuschong LM; Fowler CJ; Bauer TR; Burkholder TH; Hickstein DD
Mol Ther; 2011 Jan; 19(1):113-21. PubMed ID: 20859258
[TBL] [Abstract][Full Text] [Related]
2. Gene therapy for canine leukocyte adhesion deficiency with lentiviral vectors using the murine stem cell virus and human phosphoglycerate kinase promoters.
Hunter MJ; Zhao H; Tuschong LM; Bauer TR; Burkholder TH; Persons DA; Hickstein DD
Hum Gene Ther; 2011 Jun; 22(6):689-96. PubMed ID: 21275758
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral vectors incorporating a human elongation factor 1alpha promoter for the treatment of canine leukocyte adhesion deficiency.
Nelson EJ; Tuschong LM; Hunter MJ; Bauer TR; Burkholder TH; Hickstein DD
Gene Ther; 2010 May; 17(5):672-7. PubMed ID: 20164857
[TBL] [Abstract][Full Text] [Related]
4. Long-term follow-up of foamy viral vector-mediated gene therapy for canine leukocyte adhesion deficiency.
Bauer TR; Tuschong LM; Calvo KR; Shive HR; Burkholder TH; Karlsson EK; West RR; Russell DW; Hickstein DD
Mol Ther; 2013 May; 21(5):964-72. PubMed ID: 23531552
[TBL] [Abstract][Full Text] [Related]
5. Lentiviral Vector-Mediated Correction of a Mouse Model of Leukocyte Adhesion Deficiency Type I.
Leon-Rico D; Aldea M; Sanchez-Baltasar R; Mesa-Nuñez C; Record J; Burns SO; Santilli G; Thrasher AJ; Bueren JA; Almarza E
Hum Gene Ther; 2016 Sep; 27(9):668-78. PubMed ID: 27056660
[TBL] [Abstract][Full Text] [Related]
6. Efficiency of different fragment lengths of the ubiquitous chromatin opening element HNRPA2B1-CBX3 in driving human CD18 gene expression within self-inactivating lentiviral vectors for gene therapy applications.
Gopinath C; Chodisetty S; Ghosh A; Nelson EJR
Gene; 2019 Aug; 710():265-272. PubMed ID: 31200085
[TBL] [Abstract][Full Text] [Related]
7. Retroviral-mediated gene transfer of the leukocyte integrin CD18 into peripheral blood CD34+ cells derived from a patient with leukocyte adhesion deficiency type 1.
Bauer TR; Schwartz BR; Liles WC; Ochs HD; Hickstein DD
Blood; 1998 Mar; 91(5):1520-6. PubMed ID: 9473215
[TBL] [Abstract][Full Text] [Related]
8. Correction of the disease phenotype in canine leukocyte adhesion deficiency using ex vivo hematopoietic stem cell gene therapy.
Bauer TR; Hai M; Tuschong LM; Burkholder TH; Gu YC; Sokolic RA; Ferguson C; Dunbar CE; Hickstein DD
Blood; 2006 Nov; 108(10):3313-20. PubMed ID: 16868255
[TBL] [Abstract][Full Text] [Related]
9. Treatment of canine leukocyte adhesion deficiency by foamy virus vectors expressing CD18 from a PGK promoter.
Bauer TR; Olson EM; Huo Y; Tuschong LM; Allen JM; Li Y; Burkholder TH; Russell DW
Gene Ther; 2011 Jun; 18(6):553-9. PubMed ID: 21228879
[TBL] [Abstract][Full Text] [Related]
10. Successful treatment of canine leukocyte adhesion deficiency by foamy virus vectors.
Bauer TR; Allen JM; Hai M; Tuschong LM; Khan IF; Olson EM; Adler RL; Burkholder TH; Gu YC; Russell DW; Hickstein DD
Nat Med; 2008 Jan; 14(1):93-7. PubMed ID: 18157138
[TBL] [Abstract][Full Text] [Related]
11. Very low levels of donor CD18+ neutrophils following allogeneic hematopoietic stem cell transplantation reverse the disease phenotype in canine leukocyte adhesion deficiency.
Bauer TR; Creevy KE; Gu YC; Tuschong LM; Donahue RE; Metzger ME; Embree LJ; Burkholder T; Bacher JD; Romines C; Thomas ML; Colenda L; Hickstein DD
Blood; 2004 May; 103(9):3582-9. PubMed ID: 14715622
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Evaluation of Foamy Virus Vector-Mediated Gene Addition in Human Hematopoietic Stem/Progenitor Cells for Correction of Leukocyte Adhesion Deficiency Type 1.
Smith RH; Bloomer H; Fink D; Keyvanfar K; Nasimuzzaman M; Sancheznieto F; Dutta R; Guenther Bui K; Alvarado LJ; Bauer TR; Hickstein DD; Russell DW; Malik P; van der Loo JCM; Highfill SL; Kuhns DB; Pirooznia M; Larochelle A
Hum Gene Ther; 2022 Dec; 33(23-24):1293-1304. PubMed ID: 36094106
[No Abstract] [Full Text] [Related]
13. Improved transfer of the leukocyte integrin CD18 subunit into hematopoietic cell lines by using retroviral vectors having a gibbon ape leukemia virus envelope.
Bauer TR; Miller AD; Hickstein DD
Blood; 1995 Sep; 86(6):2379-87. PubMed ID: 7662985
[TBL] [Abstract][Full Text] [Related]
14. Conversion of the severe to the moderate disease phenotype with donor leukocyte microchimerism in canine leukocyte adhesion deficiency.
Gu YC; Bauer TR; Sokolic RA; Hai M; Tuschong LM; Burkholder T; Bacher J; Starost MF; Hickstein DD
Bone Marrow Transplant; 2006 Mar; 37(6):607-14. PubMed ID: 16444276
[TBL] [Abstract][Full Text] [Related]
15. A missense mutation in the beta-2 integrin gene (ITGB2) causes canine leukocyte adhesion deficiency.
Kijas JM; Bauer TR; Gäfvert S; Marklund S; Trowald-Wigh G; Johannisson A; Hedhammar A; Binns M; Juneja RK; Hickstein DD; Andersson L
Genomics; 1999 Oct; 61(1):101-7. PubMed ID: 10512685
[TBL] [Abstract][Full Text] [Related]
16. Canine leukocyte adhesion deficiency colony for investigation of novel hematopoietic therapies.
Creevy KE; Bauer TR; Tuschong LM; Embree LJ; Colenda L; Cogan K; Starost MF; Haskins ME; Hickstein DD
Vet Immunol Immunopathol; 2003 Jul; 94(1-2):11-22. PubMed ID: 12842608
[TBL] [Abstract][Full Text] [Related]
17. Potential genotoxicity from integration sites in CLAD dogs treated successfully with gammaretroviral vector-mediated gene therapy.
Hai M; Adler RL; Bauer TR; Tuschong LM; Gu YC; Wu X; Hickstein DD
Gene Ther; 2008 Jul; 15(14):1067-71. PubMed ID: 18369320
[TBL] [Abstract][Full Text] [Related]
18. Retroviral-mediated gene expression in human myelomonocytic cells: a comparison of hematopoietic cell promoters to viral promoters.
Malik P; Krall WJ; Yu XJ; Zhou C; Kohn DB
Blood; 1995 Oct; 86(8):2993-3005. PubMed ID: 7579392
[TBL] [Abstract][Full Text] [Related]
19. Nonmyeloablative hematopoietic stem cell transplantation corrects the disease phenotype in the canine model of leukocyte adhesion deficiency.
Bauer TR; Gu YC; Tuschong LM; Burkholder T; Bacher JD; Starost MF; Donahue RE; Sokolic RA; Hickstein DD
Exp Hematol; 2005 Jun; 33(6):706-12. PubMed ID: 15911095
[TBL] [Abstract][Full Text] [Related]
20. Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency.
Sokolic RA; Bauer TR; Gu YC; Hai M; Tuschong LM; Burkholder T; Colenda L; Bacher J; Starost MF; Hickstein DD
Biol Blood Marrow Transplant; 2005 Oct; 11(10):755-63. PubMed ID: 16182176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
